top of page
Medical Checkup

AMGEN

Trial Enrolment Status

OPEN

Disease Under Study

Asthma

Duration

About the Trial

A Phase 2, Randomized, Double-blind, Placebo-controlled, Dose Ranging Study to Assess the Efficacy and Safety of Rocatinlimab in Adult Subjects With Moderate-to-severe Asthma

Mechanism of Action:

IgG1 mAb OX40/OX40L Inhibitor

Dr. George Philteos

Principal Investigator

Dr. George Philteos

Sub-Investigator

Dr. Anushya Chelvanathan

Study Coordinator

Nusrat Jahan

bottom of page